常规时段
|
|
|
|
|
||||||||||||
|
|
|
|
|
|
|
|
| 价值评估 |
|
盈利(现时/预测)
-3.93/-4.13
|
|
企业价值
3.75B
|
| 资产负债 |
|
每股账面净值
7.62
|
| 现金流量 |
|
现金流量率
--
|
| 损益表 |
|
收益
107.94M
|
|
每股收益
0.56
|
|
同行比较
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
同行比较之报价最少15分钟延迟
|
业务概览
|
|||
| Arcellx Inc a clinical-stage biotechnology company reimagining cell therapy through the development of immunotherapies for patients with cancer and other incurable diseases. Its pipeline includes Multiple Myeloma, Acute Myeloid Leukemia, Non-Oncology, and Solid Tumors. |

64.635 
